I thought HIV drug trials were carried out on blacks in Africa.

<http://nanotechwire.com/news.asp?nid=5758>:

----- Begin Quote -----

NanoViricides, Inc., said that preliminary animal trials of the
Company's HIV therapeutic candidates have begun at a BioSafety Level 3
(BSL-3) Laboratory facility in Boston, MA. The initial results are
expected before the end of next month. These animal studies will be
conducted by Dr. Krishna Menon, PhD, VMD, MRCS, a world-renowned
authority in preclinical and toxicological studies of innovative
therapeutics.

"The purpose of this initial study is twofold: To assess therapeutic
efficacy and to determine the appropriate dosages of drug that should
be used in the later animal study," said Eugene Seymour, MD, MPH, CEO
of NanoViricides, adding further, "if initial performance goals are
met, it will be a critical first step in validating the Company's
HivCide-I as a potential treatment for HIV/AIDS. An expanded follow-on
study will then be performed by researchers at a prestigious federal
research institute."

----- End Quote -----